Current and future treatments of HIV-associated dyslipidemia

Gpihbp1-deficient mice, cultured cells, and human cohorts including 160 patients with severe hypertriglyceridemia, 600 normolipidemic Caucasian controls, and 610 Caucasian patients with hyperlipidemia

Sequencing of GPIHBP1 exons

Normolipidemic controls and hyperlipidemic patients

Identification of GPIHBP1 mutations and their functional impact on lipolytic processingsurrogate